NORRIS MEDICINES Fact Sheet, NORRIS MEDICINES Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NORRIS MEDICINES Fact Sheet    (NORS)


Last Chance: Grab Your Free Spot for Rahul Shah's Lazy Millionaire Summit


Here is the latest financial fact sheet of NORRIS MEDICINES. For more details, see the NORRIS MEDICINES quarterly results and NORRIS MEDICINES share price and chart. For a sector overview, read our pharmaceuticals sector report.

NORRIS MEDICINES Price History

Price Rs 18.0
Mkt Cap Rs m 180
Vol '000 8.8
P/E X -4.2
P/CF X -4.2
EPS (TTM) Rs -4.3
1 Day % 5.0
No. of shares m 10.00
1 Week % 33.7
1 Month % 61.8
1 Year % 200.3
52 week H/L Rs 18.0/5.5
As on Jan 21, 2022 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

NORRIS MEDICINES Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
NORRIS MEDICINES EQUITY SHARE DATA
High RsNA1726117 
Low RsNA12332 
Sales per share (Unadj.) Rs20.413.516.27.812.3 
Earnings per share (Unadj.) Rs-0.8-2.5-1.7-2.8-5.0 
Diluted earnings per shareRs-0.8-2.5-1.7-2.8-5.0 
Cash flow per share (Unadj.) Rs-0.1-1.8-1.0-2.1-4.3 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Avg Dividend yield %NM0000 
Book value per share (Unadj.) Rs4.62.00.4-2.5-7.4 
Adj. book value per shareRs4.62.00.4-2.5-7.4 
Shares outstanding (eoy) m10.0010.0010.0010.0010.00 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x01.10.90.90.4 
Avg P/E ratio x0-5.7-8.8-2.4-0.9 
P/CF ratio (eoy) x0-8.0-15.2-3.2-1.0 
Price / Book Value ratio x07.039.4-2.7-0.6 
Dividend payout %00000 
Avg Mkt Cap Rs m01441476745 
No. of employees `000NANANANANA 
Total wages/salary Rs m5349383231 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
NORRIS MEDICINES INCOME DATA
Net Sales Rs m20413516278123 
Other income Rs m11011 
Total revenues Rs m20513616279123 
Gross profit Rs m-1-19-6-22-17 
Depreciation Rs m67777 
Interest Rs m677916 
Profit before tax Rs m-12-32-20-37-40 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m-4-7-3-810 
Profit after tax Rs m-8-25-17-28-50 
Gross profit margin %-0.4-14.2-3.8-27.7-14.2 
Effective tax rate %35.121.116.622.8-24.3 
Net profit margin %-3.8-18.6-10.4-36.5-40.5 
NORRIS MEDICINES BALANCE SHEET DATA
Current assets Rs m9176747482 
Current liabilities Rs m991098880117 
Net working cap to sales %-4.2-24.4-8.5-7.7-28.2 
Current ratio x0.90.70.80.90.7 
Inventory Days Days2234295736 
Debtors Days Days856768129,399,65353,283,600 
Net fixed assets Rs m1121061029589 
Share capital Rs m9999999999 
"Free" reserves Rs m-54-79-96-124-174 
Net worth Rs m46204-25-74 
Long term debt Rs m7677112150155 
Total assets Rs m202182176169171 
Interest coverage x-1.0-3.6-1.8-3.2-1.4 
Debt to equity ratio x1.73.830.1-6.1-2.1 
Sales to assets ratio x1.00.70.90.50.7 
Return on assets %-0.8-10.0-5.4-11.6-19.5 
Return on equity %-16.8-122.6-449.5115.166.8 
Return on capital %-4.8-25.5-11.1-22.4-29.1 
Exports to sales %1.30.90.90.51.8 
Imports to sales %00000 
Exports (fob) Rs m31202 
Imports (cif) Rs m00000 
Fx inflow Rs m31202 
Fx outflow Rs m00000 
Net fx Rs m31202 
NORRIS MEDICINES CASH FLOW
From Operations Rs m -10 8 -19 -29 11 
From Investments Rs m -20 -1 -3 0 -1 
From Financial Activity Rs m 32 -7 22 29 -11 
Net Cashflow Rs m 2 1 0 0 0 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 34.0%
Institution 0.1%
Non-Institution 65.9%
Total 100.0%
Free Float 66.0%
Pledged promoter holdings 0.0%
Shareholding as on Dec 2021
 

Company Information

Regd Off Plot No. 801 / P, G I D C, Industrial Estate, Ankleshwar - 393002
E-mail secretarial@norrispharma.com Web www.norrispharma.com
Tel 02646 - 223462 227530 Fax 02646 - 250126
Sector PHARMACEUTICALS Group Private sector
Tr Agent Purva Shareregistry (India) Pvt Ltd, Gala No 9, Shiv Shakti Industrial Estate Sitaram Mill Comp., J R Boricha Marg Lower Parel [E]
YEAR OF INC: 1990 BSE CODE: 524414 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    

Compare NORRIS MEDICINES With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    




Today's Market

SBI Life Insurance Quarterly Results, Vedanta's Bid for BPCL Stake, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a weak note on Friday. Global headwinds weighed on benchmark indices for fourth straight day as all sectors, barring FMCG, slid into the negative territory.

Views on news

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

Tata Steel vs SAIL: Which Stock is Better? (Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain (Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look? (Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive? (Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks (Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK NORRIS MEDICINES

  • Track your investment in NORRIS MEDICINES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON NORRIS MEDICINES

NORRIS MEDICINES - TEVA PHARMA COMPARISON

COMPARE NORRIS MEDICINES WITH

MARKET STATS